Does working in hospital increases seroprevalence and carrier state against Bordetella pertussis?

Naeini, Alireza Emami; Zaman, Nasim; Khorvash, Farzin; Naeini, Sahar Emami; Khodadadi, Hesam-al-din; Mokhtari, Mojgan; Koushki, Ali Mehrabi

Does working in hospital increases seroprevalence and carrier state against Bordetella pertussis?

Authors

¹ Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

² Department of Infectious Diseases and Tropical Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

³ Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

⁴ Department of Infectious Diseases, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

⁵ Department of Pathology, Al Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

⁶ Department of Epidemiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Health care environments have been the setting for a number of pertussis outbreaks. Immunity after vaccination wanes overtime leading to a growing population of susceptible adolescents and adults. A number of pertussis outbreaks have occurred in hospitals resulting in transmission to health care workers (HCWs), and other patients. The aim of this study was to assess immunity status of a group of basic medical students and interns who worked in hospitals for about 4 years.
Materials and Methods: In a cross-sectional study, we measured the serum antibody titer of cases by enzyme-linked immunosorbent assay test. All 70 subjects have received pertussis vaccine in the routine childhood vaccination schedule. All cases were healthy and had no symptoms of any respiratory diseases. We also obtained a pharyngeal culture on Bordet-Gengou Agar for isolating Bordetella pertussis.
Results: The results of B. pertussis pharyngeal culture was positive for 5 (7.1%) cases and negative for 65 (92.9%). The IgM, IgA, and IgG serum antibody was positive in 1.4%, 7.1%, and 11.4% of cases, respectively. The mean age of cases had no significant effect on serum antibody titers (P = 0.23).
Conclusions: This study showed that majority of cases do not have protective serum antibody against B. pertussis. Working in hospitals does not affect seroprevalence and carrier state of B. pertussis. Immunization schedules that include no booster doses are at increased risk of pertussis. Due to the importance of the transmission in health care settings, vaccination of HCWs is a priority.

Keywords

References

1.	Sandora TJ, Gidengil CA, Lee GM. Pertussis vaccination for health care workers. Clin Microbiol Rev 2008;21:426-34.
2.	Halperin SA. Pertussis and other Bordetella infections. In: Kasper, Braunwald, Fauci, Hauser, Longo, Jameson, editor's. Harrison's Principles of Internal Medicine. 16^th ed. USA: MacGraw-Hill; 2012. p. 1241-5.
3.	Forsyth K. Pertussis still a formidable foe. Clin Infect Dis 2007;45:1487-91.
4.	Waters V, Halperin SA. Bordetella pertussis. In: Mandell, Douglas, Bennett's, editor's. Principles and Practice of Infectious Diseases. 8^th ed. USA: Churchill Livingstone; 2015. p. 2619-28.
5.	Craig AS, Wright SW, Edwards KM, Greene JW, Haynes M, Dake AD, et al. Outbreak of pertussis on a college campus. Am J Med 2007;120:364-8.
6.	Waters V, Jamieson F, Richardson SE, Finkelstein M, Wormsbecker A, Halperin SA. Outbreak of atypical pertussis detected by polymerase chain reaction in immunized preschool-aged children. Pediatr Infect Dis J 2009;28:582-7.
7.	Dashti AS, Karimi A, Arjmand R, Moghadami M, Kheirkhah T, Shiva F, et al. Serologic evidence of pertussis infection in vaccinated Iranian children. Iran J Med Sci 2012;37:260-5.
8.	Zarei S, Jeddi-Tehrani M, Akhondi MM, Zeraati H, Pourheidari F, Ostadkarampour M, et al. Primary immunization with a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian infants: An analysis of antibody response. Iran J Allergy Asthma Immunol 2009;8:85-93.
9.	Zarei S, Jeddi-Tehrani M, Akhondi MM, Zeraati H, Kheirkhah T, Ghazanfari M, et al. Immunogenicity of a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian preschool children. Iran J Immunol 2007;4:101-9.
10.	Mertsola J, Van Der Meeren O, He Q, Linko-Parvinen A, Ramakrishnan G, Mannermaa L, et al. Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults. Clin Infect Dis 2010;51:656-62.
11.	Bassinet L, Matrat M, Njamkepo E, Aberrane S, Housset B, Guiso N. Nosocomial pertussis outbreak among adult patients and healthcare workers. Infect Control Hosp Epidemiol 2004;25:995-7.
12.	Krantz I, Alestig K, Trollfors B, Zackrisson G. The carrier state in pertussis. Scand J Infect Dis 1986;18:121-3. [PUBMED]
13.	Lambert HP. The carrier state: Bordetella pertussis. J Antimicrob Chemother 1986;18 Suppl A:13-6. [PUBMED]
14.	Kerr JR, Preston NW. Current pharmacotherapy of pertussis. Expert Opin Pharmacother 2001;2:1275-82.
15.	von König CH. Use of antibiotics in the prevention and treatment of pertussis. Pediatr Infect Dis J 2005;24 5 Suppl:S66-8.
16.	Russi M, Behrman A, Buchta WG, Budnick LD, Hodgson MJ, Spillmann SJ, et al. Pertussis vaccination of health care workers: ACOEM medical center occupational health section task force on pertussis vaccination of health care workers. J Occup Environ Med 2013;55:1113-5. [PUBMED]
17.	Pichichero ME, Casey JR. Acellular pertussis vaccines for adolescents. Pediatr Infect Dis J 2005;24 6 Suppl:S117-26.
18.	Goins WP, Edwards KM, Vnencak-Jones CL, Rock MT, Swift M, Thayer V, et al. A comparison of 2 strategies to prevent infection following pertussis exposure in vaccinated healthcare personnel. Clin Infect Dis 2012;54:938-45.

Advanced Biomedical Research